The acute syndrome

Acute Vestibular Syndrome & TiTrATE

Stop asking "what kind of dizziness?" Ask "how long, and what set it off?" The temporal framing of acute dizziness is reproducible across clinicians and maps directly to the bedside test that comes next.

Trainee

Hotson and Baloh's 1998 NEJM piece defined the modern acute vestibular syndrome: acute, sustained vertigo with spontaneous nystagmus, gait unsteadiness, nausea and head-motion intolerance lasting more than 24 hours.1 It is the presentation where stroke and neuritis are the main competitors and where bedside testing has the highest leverage per minute of clinician time.

Edlow, Gurley and Newman-Toker's TiTrATE framework — Timing, Triggers, Targeted Examination — operationalises the AVS concept into a three-way triage with concrete testing pathways for each branch.2

The three branches

Acutely dizzy patient
Acute vestibular syndrome

Sustained vertigo lasting hours to days with spontaneous nystagmus and gait unsteadiness.

Next bedside step
HINTS battery. Look for hearing loss, brainstem signs.
Dominant causes
  • Vestibular neuritis
  • Posterior-circulation stroke
  • Labyrinthitis

Why timing and triggers, not symptom quality

Asking patients to describe their dizziness as "vertigo" vs "lightheadedness" produces unreliable labels. The same patient labels the same sensation differently on different occasions, and clinicians map those labels inconsistently onto diagnoses. Timing and triggers are reproducible across clinicians and map to the bedside test that follows.

Population data show that ~3–5% of dizzy ED patients are having a stroke, but stroke accounts for a disproportionate share of poor outcomes when missed.4 The TiTrATE triage is built to find that minority efficiently without dragging every dizzy patient through the same imaging algorithm.